Agaricus blazei Murill™– Mfg. by Aloha Medicinals

Agaricus blazei Murill™– Mfg. by Aloha Medicinals.
Agaricus blazei Murill Mushroom is known to support the immune system, also known as ABM or Royal Sun Agaricus, is a popular immune support supplement. It was originally found in Brazil in a region where the people are known to live longer and healthier lives than the average. When the Government studied this region to see why, they found the population there consumed Agaricus mushrooms as a regular part of their diet.
• One bag of Agaricus blazei Murill™ contains 16.0 oz/ 1 lbs. of pure Chaga Gold powder.
• 453 servings per bag.
• Dosage – 1 – one-gram servings three times per day or 1 heaping tsp per day.
Aloha Medicinals Agaricus blazei is specially grown in America from the original Brazilian strains, in an FDA certified manufacturing plant with organic ingredients, using a special solid state fermentation process to develop the highest concentration of bio-active compounds.

Agaricus blazei is commonly combined with Cordyceps to gain the benefits of both supplements. A great combo to help you live the healthier, happier life you want.
Aloha Medicinals Agaricus blazei is Certified Free of Agaratine:
We are often asked if our Agaricus blazei contains the carcinogenic compound agaratine. The answer is absolutely NO. We only grow Agaricus strains that are certified free of agaratine, and all lots are independently tested and certified free of all toxins. See independent lab report [pdf] for a typical analysis.
This product contains NO ingredients from China.
is a type of medicinal mushroom grown in Brazil, Japan, and China. It has been used in folk medicine for centuries to prevent or treat a wide range of diseases, including infections, allergy, and cancer.
Agaricus blazei is related to both the common mushroom and field mushroom but contains compounds that some believe can exert antioxidant, anti-inflammatory, antimicrobial, anti-tumor, and hypoglycemic effects.
In the West, Agaricus blazei is typically sold as a dietary supplement but is also available as a whole dried mushroom for culinary purposes. It has an aroma and smell that is vaguely reminiscent of almonds. Betulinic acid has been shown to induce mitochondrial apoptosis in different cancer cell lines and inhibit the enzyme topoisomerase2, which is essential for the unwinding and winding of the DNA strands in cell replication. In addition it possesses anti-retroviral, anti-parasitic and anti-inflammatory properties3. It is currently being developed as an anti-cancer agent through the Rapid Access to Intervention Development program of the US National Cancer Institute and is also a major contributor to the anti-cancer action of mistletoe4.
had lower rates of aging-related disorders like cancer and heart disease.1

Alternative practitioners believe that many of the compounds in the mushroom (including isoflavonoids and plant-based steroids) can prevent or treat certain health conditions, including:
• Asthma
• Atherosclerosis
• Cancer
• Dermatitis
• Diabetes
• Hepatitis
• High blood pressure
• High cholesterol
• Inflammatory bowel disease (IBD)
It is not intended to treat, diagnose or cure.

Diabetes:
Agaricus blazei mushrooms may have a place in the treatment of type 2 diabetes, says a 2017 review of studies in the World Journal of Diabetes. According to the researchers, Agaricus blazei contains beta-glucan (a type of dietary fiber) and oligosaccharides (a type of carbohydrate). Both are known to improve blood glucose levels by reducing the inflammatory stress on the pancreas (the body’s primary source of insulin).
When used in combination with the anti-diabetes drug metformin, a daily 1,500-milligram dose of Agaricus blazei was able to improve insulin resistance and cut blood sugar levels by half compared to people given metformin alone.
Despite the promising findings, there has yet to any evidence that Agaricus blazei can control diabetes on its own or prevent the onset of diabetes in people with prediabetes.

Inflammatory Bowel Disease:
Agaricus blazei mushrooms appear to exert potent anti-inflammatory effects that may benefit people with inflammatory bowel diseases, including ulcerative colitis and Crohn’s disease.
According to a 2011 study in the Scandinavian Journal of Immunology, adults with Crohn’s disease experienced a significant reduction in intestinal inflammation when prescribed an oral Agaricus extract called AndoSan for 12 days.
At the end of the study period, people given AndoSan had between an 18% and 78% reduction in 17 different inflammatory proteins (called cytokines) in blood and stool tests. These effects are considered indicative of an improvement in IBD symptoms.
Further research is needed to determine how effective Agaricus blazei is in either sustaining IBD remission or treating an acute flare of symptoms.

Hepatitis:
In the same way that Agaricus blazei helps reduce inflammation in the pancreas and intestines, it may help alleviate the inflammation that drives chronic hepatitis infections.
A small study published in the Journal of Alternative and Complementary Medicine reported that adults with chronic hepatitis B experienced a steep drop in liver enzymes (indicative of improved liver function) after being prescribed a daily 1,500-milligram dose of Agaricus blazei.

After 12 months, the participants experienced no less than a three- and four-fold drop in their alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, respectively. This suggests a significant slowing in the disease progression.
On the flip side, a 2013 study in the Clinical Journal of Gastroenterology reported that a man and woman sustained severe liver damage after taking an Agaricus blazei extract as a complementary therapy for stage 4 lung cancer and stage 3 thymus cancer, respectively.
Neither disclosed the use of the extract to their doctors, and it can only be presumed that high doses may have contributed to the effect. According to the researchers, the damage appeared autoimmune in nature, suggesting that the mushroom may have in some way triggered an abnormal immune response.

Cancer
Several preliminary studies have suggested that Agaricus blazei has anti-tumor properties. While the mechanism of action is unclear, Agaricus blazei appears to “switch on” apoptosis (programmed cell death) in certain cancer cells, including those involved in multiple myeloma, leukemia, fibrosarcoma, prostate cancer, ovarian cancer, and lung cancer.
According to a 2011 review published in Advances in Pharmacological Sciences, Agaricus blazei was able to prevent the spread (metastasis) of ovarian and lung cancer, inhibit the growth of fibrosarcoma and myeloma tumors, and reduce the size of prostate tumors in animal and test-tube studies. However, not all of the results have been consistent.
At present, it is impossible to say if any of these effects can be replicated in humans. Further research is needed.
It is not intended to treat, diagnose or cure.